ASHUMGulf news and Dubai stocks, live

Financial Statements for the period from January 2024 to December 2024 CHAE

Lunate S&P UAE UCITS ETF - Share A - ACCUMLATING 83 pages

Document83 pages, text from the file; its scanned pages read by AshumOpen DFM’s file

Page 1

30 /04/ 2025

Mr. Hamed Ahmed Ali

CEO

Dubai Financial Market (DFM)

Dubai, United Arab Emirates

Greetings,

Subject: Notification by Lunate Capital Limited on behalf of Chimera UCITS ICAV

Please be informed that Lunate Capital Limited received the enclosed Annual Report and Audited Financial Statements from Chimera UCITS ICAV for the Period 1st of January 2024 to 31st of January 2024.

Sincerely,

Sherif SalemHead of Public Markets

٣٠ / ٠٤ / ٢٠٢٥

السيد / حامد أحمد علي المحترم

الرئيس التنفيذي

سوق دبي المالي (DFM)

دبي، دولة الإمارات العربية المتحدة

تحية طيبة وبعد،

الموضوع: اخطار من شركة لونيت كابيتال ليمتد عن شيميرا يوسيتس ايكاف

نود اعلامكم بأن شركة لونيت كابيتال ليمتد استلمت التقرير السنوي و البيانات المالية من شيميرا يوسيتس ايكاف للفترة من ١ يناير ٢٠٢٤ إلى ٣١ يناير ٢٠٢٤.

وتفضلوا بقبول وافر الاحترام،

شريف سالمرئيس قطاع الاستثمار – الأسواق المالية

مرفق التقرير السنوي و البيانات من شيميرا يوسيتس ايكاف

Attached: Chimera UCITS ICAV Annual Report and Audited Financial Statements

LUNATE CAPITAL LIMITED12TH FLOOR, ALMARYAH TOWER,ABU DHABI,UNITED ARAB EMIRATESLUNATE.COM

Lunate Capital Limited is duly licensed and regulated by the ADGM Financial Services Regulatory Authority

Page 2

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2024ICAV Registration Number: C188915

Page 3

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2024Contents PageDirectors and Other Information 1Directors’ Report 2Report from the Depositary to the Shareholders 6Investment Manager’s Report 7Independent Auditor’s Report 15Statement of Financial Position 22Statement of Comprehensive Income 24

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares 26

Statement of Cash Flows 28Notes to the Audited Financial Statements 30Schedule of Investments 58Statement of Portfolio Changes (Unaudited) 67Appendix I: UCITS V Remuneration Policy (Unaudited) 78

Appendix II: Securities Financing Transactions Regulation (“SFTR”) Disclosures (Unaudited) 79

Appendix III: Sustainable Finance Disclosure Regulation (“SFDR”) Disclosures (Unaudited) 80

Page 4

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 1

Directors and Other InformationDirectors of the ICAVFeargal Dempsey (Irish)1Seif Fikry (Egyptian)2Jason Loveless (British)2Syl O’Byrne (Irish)1Sherif Salem (Egyptian)2ManagerFrom 1 January 2025

FundRock Management Company S.A.

5, HeienhaffL-1736 SenningerbergGrand Duchy of LuxembourgUntil 31 December 2024

FundRock Management Company S.A.

33, rue de GasperichL-5826 HesperangeGrand Duchy of LuxembourgRegistered Office of the ICAVArthur Cox BuildingTen Earlsfort TerraceDublin 2D02 T380IrelandSecretaryBradwell LimitedTen Earlsfort TerraceDublin 2D02 T380IrelandIndependent AuditorsDeloitte Ireland LLP

Chartered Accountants and Statutory Auditors 29 Earlsfort Terrace

Dublin 2D02 AY28Ireland

Investment Manager and Global Distributor Lunate Capital Limited

12th Floor, Al Maryah TowerAl Maryah IslandAbu DhabiUnited Arab EmiratesDepositary

The Bank of New York Mellon SA/NV, Dublin Branch Riverside II

Sir John Rogerson’s QuayGrand Canal DockDublin 2IrelandAdministrator, Registrar and Transfer AgentBNY Mellon Fund Services (Ireland)Designated Activity CompanyOne Dockland CentralGuild Street

International Financial Services Centre Dublin 1

IrelandIrish Legal AdvisersArthur CoxTen Earlsfort TerraceDublin 2D02 T380Ireland

1 Independent and Non-executive Director.

2 Non-executive Director.

Page 5

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024

2Directors’ Report

The Board of Directors (the “Directors”) present their Annual Report together with the audited financial statements of the Chimera UCITS ICAV (the “ICAV”) for the financial year ended 31 December 2024 (the “financial year”).

Statement of Directors' Responsibilities

The Directors are responsible for preparing the Directors’ Report and financial statements of Chimera UCITS ICAV, in accordance with applicable law and regulations.

The Irish Collective Asset-Management Vehicles Act 2015 and 2020 (the “ICAV Act”) Section 116 requires the Directors to prepare financial statements for each financial year. Under that law they have elected to prepare the financial statements in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the European Union (“EU”) and applicable law.

Under the ICAV Act the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the assets, liabilities and financial position of the ICAV and of its changes in net assets attributable to holders of redeemable participating shares for that financial year. In preparing the financial statements, the Directors are required to:

 select suitable accounting policies and then apply them consistently;

 make judgements and estimates that are reasonable and prudent;

 state whether the financial statements have been prepared in accordance with IFRS and ensure that they contain the additional information required by the ICAV Act;

 assess the ICAV's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and  prepare the financial statements on the going concern basis unless it is inappropriate to presume that the ICAV will continue in business.

The Directors confirm that they have complied with the above requirements in preparing the financial statements.

The Directors are also responsible for safeguarding the assets of the ICAV and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Under the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations, 2011, as amended (the “UCITS Regulations”), the Central Bank (Supervision and Enforcement Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (the “Central Bank UCITS Regulations”), the Directors are required to entrust the assets of the ICAV to a depositary for safekeeping. In carrying out this duty, the Directors have delegated custody of the ICAV’s assets to The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary”). They have general responsibility for taking such steps as are reasonably open to them to prevent and detect fraud and other irregularities. The Directors are also responsible for preparing a Directors’ Report that complies with the requirements of the ICAV Act.

Adequate Accounting Records

The ICAV has appointed FundRock Management Company S.A. as its Manager (the “Manager”) pursuant to the Management Agreement. Under the terms of the Management Agreement, the Manager has responsibility for the management and administration of the ICAV’s affairs and the distribution of the shares, subject to the overall supervision and control of the Directors.

The Manager has delegated the administration and transfer agency functions to an administrator and has therefore appointed BNY Mellon Fund Services (Ireland) Designated Activity Company to act as administrator (the “Administrator”), registrar and transfer agent of the ICAV with responsibility for performing the day to day administration of the ICAV.

The Directors believe that they have complied with the requirements of Sections 109 to 113 of the ICAV Act, with regard to keeping adequate accounting records in respect of the ICAV by appointing the Administrator which has appropriate expertise, adequate resources and appropriate systems and procedures. The accounting records of the ICAV are kept by the Administrator at their registered office at: One Dockland Central, Guild Street, International Financial Services Centre, Dublin 1, D01 E4XO, Ireland.

Page 6

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 3

Directors’ Report (continued)Corporate Governance StatementThe ICAV is subject to corporate governance practices imposed by:

(i) The ICAV Act, which is available for inspection at the registered office of the ICAV, and may also be obtained at http://www.irishstatutebook.ie;

(ii) The Instrument of Incorporation of the ICAV which is available for inspection at the registered office of the ICAV at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland;

(iii) The Central Bank of Ireland (“CBI”) in their UCITS Regulations which can be obtained from the CBI website at www.centralbank.ie and are available for inspection at the registered office of the ICAV.

From the inception of the ICAV, the Directors voluntarily adopted and applied the Irish Funds’ Corporate Governance Code (the “IF Code”) for Irish domiciled collective investment schemes and management companies as published by the Irish Funds, the full text of which is available from the Irish Funds’ website at www.irishfunds.ie. The ICAV has been fully compliant with the corporate governance practices during the financial year.

The ICAV is not subject to the amendments to general corporate law required by any European directives.

Composition and Operation of the Board of Directors

Unless otherwise determined by an ordinary resolution of the ICAV in general meeting and in accordance with Section 56 of the ICAV Act, the number of Directors may not be less than two or more than twelve. Currently the Board of Directors of the ICAV is composed of five Directors.

The business of the ICAV is managed by the Directors, who exercise all such powers of the ICAV which are not required by the ICAV Act or by the Instrument of Incorporation of the ICAV to be exercised by the ICAV in a general meeting. The Directors meet on a quarterly basis or more frequently, if required.

A Director may, and the Secretary of the ICAV on the requisition of a Director will, at any time summon a meeting of the Directors. Questions arising at any meeting of the Directors are determined by a majority of votes. In the case of an equality of votes, the Chairman has a second or casting vote. The quorum necessary for the transaction of business at a meeting of the Directors is two.

Directors and Secretary

The Directors that served at any time during the financial year are listed in the Directors and Other Information on page 1.

Bradwell Limited held the office of ICAV Secretary (the “Secretary”) throughout the financial year.

Directors’ Remuneration

The Board of Directors as a whole reviews Directors’ remuneration. The Director’s policy is that the remuneration of independent non-executive Directors should be fair and reasonable in relation to the time commitment and responsibilities of the Directors. The fees of the independent non-executive Directors are paid by the ICAV. The other Directors are not entitled to any fees.

Directors’ and Secretary’s Interests in Shares and Contracts

The Directors, Secretary and their families had no interest in the shares of the ICAV at 31 December 2024. Other than as disclosed in Note 10 to the Financial Statements, none of the Directors had a material interest in any contract or agreement of significance, as defined in the ICAV Act, during or at the end of the financial year in relation to the business of the ICAV.

Employees

The governance framework of the ICAV reflects the fact that it has no employees or subsidiary companies and outsources investment management, distribution and administration.

Page 7

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 4

Directors’ Report (continued)Transactions with Connected Persons

Regulation 43 of the Central Bank UCITS Regulations “Restrictions of transactions with connected persons” states that “A responsible person shall ensure that any transaction between a UCITS and a connected person is conducted a) at arm’s length; and b) in the best interest of the shareholders of the UCITS”.

As required under the Central Bank UCITS Regulation 81 (4), the Manager, as responsible person, has confirmed to the Board of Directors of the ICAV that it is satisfied that there are arrangements in place, evidenced by written procedures, to ensure that obligations set out in Regulation 43(1) are applied to all transactions with connected persons; and all transactions with connected persons that were entered into during the financial year to which the report relates, complied with the obligations that are prescribed by Regulation 43(1).

Principal Activities, Review of the Business and Future Developments

The ICAV is an open-ended Irish collective asset-management vehicle with segregated liability between Sub-Funds established under the laws of Ireland pursuant to the ICAV Act, the UCITS Regulations and the Central Bank UCITS Regulations. It was incorporated on 21 January 2019.

Each Sub-Fund may comprise one or more classes of shares in the ICAV. The Directors may, from time to time, upon the prior approval of the CBI, establish further Sub-Funds by the issue of one or more separate classes of shares on such terms as the Directors may resolve.

As at 31 December 2024, the ICAV consisted of five Sub-Funds - Chimera S&P UAE UCITS ETF (the "Sub-Fund"), launched on 23 February 2021; Chimera S&P Pakistan UCITS ETF (the "Sub-Fund), launched on 17 August 2023; Chimera JP Morgan UAE Bond UCITS ETF (the "Sub-Fund"), launched on 25 March 2024; Chimera S&P Japan UCITS ETF (the "Sub-Fund"), launched on 28 May 2024; and Chimera S&P Germany UCITS ETF (the "Sub-Fund"), launched on 25 September 2024.

The Investment Manager's Report from pages 7 to 14 contains a review of the factors which contributed to the performance for the financial year ended 31 December 2024.

Principal Risks and Uncertainties

The main risks arising from the ICAV's financial instruments are Investment strategy, Pricing and Valuation Risk, Counterparty

Credit & Settlement Risk, Foreign Currency Risk, Credit Risk with respect to Cash, Interest Rate Risk, Liquidity Risk, Global

Exposure and Fair Value which are outlined in Note 3 to these financial statements. Risk information is outlined in the Prospectus.

The maintenance and integrity of the financial statements published on the Chimera website are the Directors' responsibility, and may also be obtained at (https://www.chimerainvestment.com/Website/en/capitalllc.html).

Going Concern

The ICAV and Sub-Funds will continue in business and the financial statements have been prepared on a going concern basis.

Relevant Audit Information

So far as the Directors are aware, there is no relevant audit information of which the ICAV’s auditors are unaware and the Directors have taken all the steps that should have been taken as Directors in order to make themselves aware of any relevant audit information and to establish that the ICAV’s auditors are aware of that information.

Page 8

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 5

Directors’ Report (continued)Results and Dividends

The results for the financial year are set out in the Statement of Comprehensive Income. The Directors are empowered by the Instrument of Incorporation to declare and pay dividends, in respect of Shares in any Distributing Share Class out of net income (including dividend and interest income) and/or capital. Dividends paid out of capital are designed to a return or withdrawal of part of a Shareholder’s original investment or from any capital gains attributable to that original investment. It is not the current intention of the Directors to declare dividends in respect of the Sub-Funds.

Independent Auditors

Deloitte Ireland LLP, Chartered Accountants and Statutory Audit Firm, have indicated their willingness to continue as auditors in accordance with the ICAV Act 2015.

On behalf of the Board of Directors:Director:______________________ Director:______________________Feargal Dempsey Syl O'ByrneDate: 23 April 2025

Page 9

The Bank of New York Mellon SA/NV, T +353 1 900 7920 Dublin Branch

Riverside Two, Sir John Rogerson’s QuayGrand Canal Dock, Dublin 2, D02 KV60, Ireland.Registered in Ireland No. 907126, VAT No. IE9578054E

The Bank of New York Mellon SA/NV, trading as The Bank of New York Mellon SA/NV, Dublin Branch is authorised by the National Bank of Belgium.

The Bank of New York Mellon SA/NV, Boulevard Anspachlaan 1, B-1000 Brussels Belgium – Tel. (32) 2 545 81 11, V.A.T. BE 0806.743.159-RPM-RPR Brussels Company No. 0806.743.159. The Bank of New York Mellon SA/NV is a Belgian limited liability company, authorized and regulated as a significant credit institution by the European Central Bank and the National Bank of Belgium under the Single Supervisory Mechanism and by the Belgian Financial Services and Markets Authority.

Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2024Report from the Depositary to the Shareholders

For the financial period from 1 January 2024 to 31 December 2024 (the “Period”). The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary” “us”, “we”, or “our”), has enquired into the conduct of Chimera UCITS ICAV (the “ICAV”) for the Period, in its capacity as depositary to the ICAV. This report including the opinion has been prepared for and solely for the Shareholders in the ICAV, in accordance with our role as depositary to the ICAV and for no other purpose. We do not, in giving this opinion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown.

Responsibilities of the Depositary

Our duties and responsibilities are outlined in Regulation 34 of the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011 (S.I. No 352 of 2011), as amended (the “Regulations”).

Our report shall state whether, in our opinion, the ICAV has been managed in that period in accordance with the provisions of the ICAV’s constitutional documents and the Regulations. It is the overall responsibility of the ICAV to comply with these provisions. If the ICAV has not been so managed, we as depositary must state in what respects it has not been so managed and the steps which we have taken in respect thereof.

Basis of Depositary Opinion

The Depositary conducts such reviews as it, in its reasonable opinion, considers necessary in order to comply with its duties and to ensure that, in all material respects, the ICAV has been managed (i) in accordance with the limitations imposed on its investment and borrowing powers by the provisions of its constitutional documentation and the appropriate regulations and (ii) otherwise in accordance with the ICAV’s constitutional documentation and the appropriate regulations.

Opinion

In our opinion, the ICAV has been managed during the Period, in all material respects:

(i) in accordance with the limitations imposed on the investment and borrowing powers of the ICAV by the constitutional documentation and by the Regulations; and

(ii) otherwise in accordance with the provisions of the constitutional documentation and the Regulations.


For and on behalf of The Bank of New York Mellon SA/NV, Dublin BranchRiverside II,Sir John Rogerson’s Quay,Grand Canal Dock,Dublin 2Date: 23 April 2025

Page 10

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024

7Investment Manager’s Report

The Chimera UCITS ICAV Fund ended the second half of 2024 with assets under management of AED 194.3 million. As of the end of December, there are five sub-funds under the Chimera UCITS ICAV Fund, of which one was launched in February 2021, one was launched in August 2023, and the last three were launched in 2024. The sub-funds are the Chimera S&P UAE UCITS ETF (“the First Sub-Fund”), the Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”), the Chimera JP Morgan UAE Bond UCITS ETF (“the Third Sub-Fund”), the Chimera S&P Japan UCITS ETF (“the Fourth Sub-Fund”), and Chimera S&P Germany UCITS ETF (“the Fifth Sub-Fund”).

Chimera S&P UAE UCITS ETF (“the First Sub-Fund”)

The Chimera S&P UAE UCITS ETF has two share classes launched on 23 February 2021, an accumulating share class listed on the Dubai Financial Market (DFM) that replicates the S&P UAE BMI Liquid 20/35 Capped Index NTR (Bloomberg Code:

SPUAECAN) and an income share class listed on the Abu Dhabi Securities Exchange (ADX) that replicates the S&P UAE BMI Liquid 20/35 Capped Index (Bloomberg Code: SPUAECAP). The dividends received by the fund’s income share class are intended to be distributed semi-annually when available. As of 31st December 2024, the DFM-listed Share Class A (Bloomberg code: CHAE) had a NAV of AED 5.632, and the ADX-listed Share Class D (Bloomberg code: CHAEIN) had a NAV of AED 4.949.

The return for the ETF for 2024 was 17.0% versus the S&P UAE BMI Liquid 20/35 Capped Index’s (the “Index”) return of 18.3%. Since inception, the fund’s return is 53.5% versus the index’s 59.7% return.

In the fourth quarter of 2024, a dividend of AED 0.0819 was announced for the ADX-listed Share Class D. The ex-dividend date was 19 December 2024, and the payment date is 10 January 2025. This brings the total dividends for 2024 for the ETF to AED 0.1795 and translates into a yield of 3.6% based on the end-of-December NAV.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

3.54.04.55.05.56.06.5AEDNAV PerformanceChimera ETF SPUAECAN

Page 11

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 8

Investment Manager’s Report (continued) Tracking Difference & Tracking Error

The Fund's tracking difference in 2024 was -129.3 bps, of which 94.3 bps were management fees, resulting in a gross tracking difference of -35.1 bps.

2021 2022 2023 2024 ITD

ETF Return35.1%-4.8%2.0%17.0%53.5%

Index Return36.4%-3.9%2.9%18.3%59.7%

Tracking Diff (bps)-133.1-90.4-97.7-129.3-623.1

Total Expense Ratio (bps)88.671.495.094.3375.0

Tracking Diff gross (bps)-44.5-18.9-2.7-35.1-248.0

Annualized Tracking Error (bps)33.413.413.010.918.6

As stated under the Investment Policy of the Chimera S&P UAE UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

Assets Under Management

The Assets Under Management (AUM) of the Chimera S&P UAE UCITS ETF Fund as of 31 December 2024 was AED 141.4 million. The AUM of Share Class D – Distributing (CHAEIN), listed on the Abu Dhabi Securities Exchange (ADX) were AED 138.6 million, while the AUM of Share Class – A – Accumulating (CHAE), listed on the Dubai Financial Market (DFM) were AED 2.8 million as of 31 December 2024.

During 2024, the ADX-listed share class (CHAEIN) traded AED 2.4 million. Meanwhile, the DFM-listed share class (CHAE) traded AED 92.5 thousand in the secondary market.

The S&P UAE BMI Liquid 20/35 Capped Index was rebalanced twice in the second half of 2024. In the third quarter, there were two additions and two deletions while the fourth quarter also had two additions and two deletions implemented.

Market Commentary

According to the Central Bank of the UAE, the GDP growth outlook for 2024 has been adjusted upward to 4.0%, slightly higher than the previous estimate of 3.9%. This revision reflects the stronger-than-anticipated performance in the oil sector. Tourism, transportation, financial and insurance services, construction, real estate, and communications are key drivers of growth.

However, the current oil production levels for 2024 are expected to temper overall growth to some extent. Looking ahead to 2025, the growth rate is projected to rise to 6%, supported by continued expansion in non-oil sectors and a substantial increase in hydrocarbon production.

The Central Bank notes that notable uncertainties influence these projections. Potential risks include heightened geopolitical tensions, a global slowdown resulting from persistently high interest rates, and the possibility of additional oil production cuts by OPEC+. Conversely, a decrease in interest rates in developed economies could act as a growth catalyst by boosting external demand and encouraging capital flows into emerging markets.

Over 2024, most sectors within the S&P UAE BMI Liquid 20/35 Capped Index delivered mixed returns. Real estate and financials were the top contributors, with the sectors gaining 67.6% and 20.3%, respectively. In real estate, Emaar Properties led the way with a notable 72.8% increase, while Abu Dhabi listed Aldar Properties rose by 48.0% over the same period. In the financial sector, Emirates NBD and Abu Dhabi Islamic Bank stood out, with gains of 32.6% and 45.8%, respectively.

Page 12

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 9

Investment Manager’s Report (continued)Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”)

The Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. The fund replicates the S&P Pakistan BMI Liquid 20/35 Capped Index (Bloomberg code: SPPKRCAP), which tracks the performance of the 15 biggest and most liquid stocks listed on the Pakistan Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: CHPKIN) – and dividends received by the fund are intended to be distributed semi-annually when available.

As of 31 December 2024, the fund’s NAV was PKR 658.729 (AED 8.688). In 2024, the fund's return in PKR (the base currency) was 79.7% versus the S&P Pakistan BMI Liquid 20/35 Capped Index’s (the “Index”) return of 81.1%. Since inception, the fund’s return is 122.5% versus the index’s 116.2% return.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Tracking Difference

The tracking difference for the Fund in 2024 was -135.9 bps, of which 97.9 bps is attributed to management fees, resulting in a gross tracking difference of -38.0 bps. One of the primary causes of this variance is that the fund paid a realized CGT of approximately 43 bps in August 2024. Since the index is a price return index, it does not account for dividends. In 2024, the annualized tracking error was 76.0 bps.

2023 2024 ITD

Fund Return*23.8%79.7%122.5%

Index Return*19.4%81.1%116.2%

Tracking Diff (bps)442.0-135.9632.1

Total Expense Ratio (bps)36.697.9135.3

Tracking Diff gross (bps)478.6-38.0767.4

Annualized Tracking Error (bps)29.076.066.8

*All returns are in base currency (PKR); Performance returns/figures previously reported in AED will now be reported in the base currency.

As stated under the Investment Policy of the Chimera S&P Pakistan UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

3.04.05.06.07.08.09.010.0AEDNAV Performance in AEDChimera ETF SPPKRCAP

Page 13

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 10

Investment Manager’s Report (continued)Assets Under Management

As of 31 December 2024, the Chimera S&P Pakistan UCITS ETF had Assets Under Management (AUM) of PKR 658.7 million (AED 8.7 million). During 2024, the ETF witnessed no primary activity. In the secondary market, the ETF traded for AED 227.7 thousand.

There were neither addition nor deletions during the third quarter and the fourth quarter rebalancing of the S&P Pakistan BMI Liquid 20/35 Capped Index.

Market Commentary

Pakistan's economic recovery is gaining momentum, with GDP growth rebounding to 2.4% in 2024 from a contraction the previous year. Agriculture led this recovery, achieving its highest growth in 19 years, while services and manufacturing also showed positive trends. Inflation eased to 23.4%, supported by stable exchange rates and improved agricultural output, though domestic energy prices remained elevated. The current account deficit narrowed to its smallest level in 13 years at 0.2% of GDP, aided by strong remittances and a surplus in the balance of payments. Fiscal consolidation reduced the fiscal deficit to 6.8% of GDP, with notable revenue growth from tax and non-tax sources. However, challenges persist, including high public debt, modest growth in industrial output, and limited private sector credit access. Continued reforms, particularly in the energy and financial sectors, remain crucial to sustaining this recovery.

In 2024, the energy sector emerged as the best-performing sector within the S&P Pakistan BMI Liquid 20/35 Capped Index, gaining 149.0% in AED terms. The materials sector secured the second position, delivering positive returns of 115.6% in AED terms. On the contrary, the industrial sector declined, emerging as the worst-performing sector during the same period, with negative returns of 10.1%.

Chimera JP Morgan UAE Bond UCITS EFT ("the Third Sub-Fund")

The Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. The fund aims to replicate the performance of the J.P Morgan MECI UAE Investment Custom Index, which tracks the performance of liquid, USD-denominated investment-grade instruments from the United Arab Emirates (UAE). The fund has one share class – Share Class D Distributing (Bloomberg code: JPEIMIGC) – and interest received by the fund are intended to be distributed semi-annually when available.

The ETF ended 2024 with an NAV of USD 1.019 (AED 3.743). From inception to the end of 2024, the fund's return in USD (the base currency) was 1.9% versus the J.P Morgan MECI UAE Investment Custom Index’s (the “Index”) return of 3.1%.

* The Fund and Index data specified in the graph are calculated since inception of the Fund

3.553.603.653.703.753.803.853.903.95AEDNAV Performance in AEDChimera ETF JPEIMIGC

Page 14

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 11

Investment Manager’s Report (continued)Tracking Difference & Tracking Error

From inception in March 2024 to the end of 2024, BONDAE had a return of 1.9%, while the index returned 3.1% over the same period resulting in a tracking difference of 122.9bps. Gross of the ETF’s total expense ratio, the tracking difference was 38.6bps.

For the same period, the annualized Tracking Error was 62.2bps.ITDFund Return* 1.9%Index Return* 3.1%Tracking Diff (bps) -122.9Total Expense Ratio (bps) 38.6Tracking Diff gross (bps) -84.3Annualized Tracking Error(bps)62.2

*All returns are in base currency (USD); figures since inception on March 25th, 2024.

As stated under the Investment Policy of the Chimera JP Morgan UAE Bond UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference gross of fees shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

Assets Under Management

As of 31 December 2024, the Chimera JP Morgan UAE Bond UCITS ETF had Assets Under Management (AUM) of USD 5.1 million (AED 18.7 million). During 2024, the ETF witnessed a primary activity of AED 29.5 million. In the secondary market, the total traded value of the ETF traded for AED 19.4 million.

There were six monthly rebalancings of the J.P Morgan MECI UAE Investment Custom Index from July to December, resulting in a total of 19 additions and 2 deletions. Given that the ETF follows a sampling strategy, the ETF had 10 additions and 12 deletions during the same period.

Market Commentary

US economic growth remained resilient, driven primarily by strong service consumption. Third-quarter 2024 GDP showed a 2.7% year-over-year increase, supported by robust service consumption and rising fixed non-residential investments. The IMF raised its 2024 US growth forecast to 2.8%, citing strong consumption and increasing real wage growth. It projects output growth to be 2.2% in 2025 due to cooling labor market and tightening fiscal policy.

In this context, the US Treasury curve has steepened since July 2024 as markets evaluate the trajectory of growth and inflation pushing global yields higher. Abu Dhabi's CDS experienced fluctuations since July due to geopolitical tensions but closed the period near its starting level.

Chimera S&P Japan UCITS ETF (“the Fourth Sub-Fund”)

The Chimera S&P Japan UCITS ETF was launched on 28 May 2024. The fund replicates the S&P Japan BMI Liquid 35/20 Capped Index (Bloomberg code: SPJPLCAP), which tracks the performance of the 30 biggest and most liquid stocks listed on the Tokyo Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: JPANI) – and dividends received by the fund are intended to be distributed semi-annually when available.

As of 31 December 2024, the fund’s NAV was JPY 160.020 (AED 3.723). From inception to the end of December 2024, the fund's return in JPY (the base currency) was 1.9%, compared to the S&P Japan BMI Liquid 35/20 Capped Index’s (the “Index”) return of 1.6%.

Page 15

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 12

Investment Manager’s Report (continued)

* The Fund and Index data specified in the graph are calculated since the inception of the Fund Tracking Difference

The Fund's tracking difference in 2024 was +35.4 bps, of which 57.0 bps is attributed to management fees, resulting in a gross tracking difference of +92.4 bps. In 2024, the annualized tracking error was 22.0 bps.

2024*Fund Return* 1.9%Index Return* 1.6%Tracking Diff (bps) 35.4Total Expense Ratio (bps) 57.0Tracking Diff gross (bps) 92.4Annualized Tracking Error (bps) 22.0

*All returns are in base currency (JPY); figures since inception on 28 May 2024.

As stated under the Investment Policy of the Chimera S&P Japan UCITS ETF Supplement, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.

Assets Under Management

As of 31 December 2024, the Chimera S&P Japan UCITS ETF had Assets Under Management (AUM) of JPY 560.1 million (AED 13.0 million). During the year, there was total primary trading activity of AED 31.4 million. In the secondary market, the ETF traded for AED 15.3 million.

The S&P Japan BMI Liquid 35/20 Capped Index was rebalanced once in the second half of 2024. The fourth quarter rebalancing had three additions and three deletions.

Page 16

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 13

Investment Manager’s Report (continued)Market Commentary

According to the International Monetary Fund (IMF), Japan's economic growth slowed from 1.7% in 2023 to 0.3% in 2024 because of supply disruptions. However, Japan’s real GDP growth is expected to recover to 1.1% in 2025, as robust real wage growth supports private consumption. Following the exit from unconventional monetary policy, the boost in nominal wages from the Shunto wage negotiations is expected to support re-anchoring inflation at the Bank of Japan’s target of 2%. Inflation rates are forecasted to decline from 2.2% in 2024 to 2.0% in 2025.

From the inception date of JPANI on 28 May 2024 until the end of December 2024, financials and industrials emerged as the best-performing sectors within the S&P Japan BMI Liquid 20/35 Capped Index, gaining 46.3% and 34.7%, respectively, in AED terms.

On the contrary, utilities were the worst-performing sector during the same period, with negative returns of 56.2%.

Chimera S&P Germany UCITS ETF (“the Fifth Sub-Fund”)

The Chimera S&P Germany UCITS ETF was launched on 25 September 2024. The fund replicates the S&P Germany BMI Liquid 35/20 Capped Index (Bloomberg code: SPDELCAP), which tracks the performance of the 30 biggest and most liquid stocks listed on the German Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: GRMNY)

– and dividends received by the fund are intended to be distributed semi-annually when available.

As of 31 December 2024, the fund’s NAV was EUR 0.935 (AED 3.566). From inception to the end of December 2024, the fund's return in EUR (the base currency) was 4.0%, compared to the S&P Germany BMI Liquid 35/20 Capped Index’s (the “Index”) return of 4.4%.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Page 17

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 14

Investment Manager’s Report (continued)Tracking Difference

The Fund's tracking difference in 2024 was -37.5 bps, of which 26.3 bps is attributed to management fees, resulting in a gross tracking difference of -11.2 bps. In 2024, the annualized tracking error was 14.4 bps.

2024*Fund Return* 4.0%Index Return* 4.4%Tracking Diff (bps) -37.5Total Expense Ratio (bps) 26.3Tracking Diff gross (bps) -11.2Annualized Tracking Error (bps) 14.4

*All returns are in base currency (EUR); figures since inception on 25 September 2024.

As stated under the Investment Policy of the Chimera S&P Germany UCITS ETF Supplement, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.

Assets Under Management

As of 31 December 2024, the Chimera S&P Germany UCITS ETF had Assets Under Management (AUM) of EUR 3.3 million (AED 12.5 million). During the year, there was total primary trading activity of AED 12.9 million. In the secondary market, the ETF traded for AED 3.9 million.

The S&P Germany BMI Liquid 35/20 Capped Index was rebalanced once in the second half of 2024. The fourth quarter rebalancing had one addition and one deletion.

Market Commentary

Germany’s economy is expected to contract by 0.1% in 2024, according to the European Commission, marking a second consecutive year of negative growth due to weak domestic and foreign demand, sluggish investment, and challenges in the construction sector. Inflation has eased significantly to an average of 2.4%, boosting real wages and modestly supporting household consumption. Economic growth is forecast to rebound gradually, with GDP expected to grow by 0.7% in 2025 and 1.3% in 2026, driven by recovering domestic demand, government tax incentives, and easing financing costs. The labor market, while softening, is expected to stabilize as growth resumes. Meanwhile, fiscal management remains cautious, with the government deficit projected to decline steadily from 2.2% of GDP in 2024 to 1.8% by 2026, alongside a stable debt-to-GDP ratio of around 63%.

From the inception date of GRMNY on 25 September 2024 until the end of December 2024, information technology and communication services emerged as the best-performing sectors within the S&P Germany BMI Liquid 35/20 Capped Index, gaining 39.6% and 29.0%, respectively, in AED terms. On the contrary, health care was the worst-performing sector during the same period, with negative returns of 24.0%.

Lunate Capital LimitedDate: January 2025

Page 18

Continued on next page/

Deloitte Ireland LLP Chartered Accountants & Statutory Audit

FirmINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAVReport on the audit of the financial statementsOpinion on the financial statements of Chimera UCITS ICAV (‘ICAV’)In our opinion the financial statements:

• give a true and fair view of the assets, liabilities and financial position of the ICAV as at 31 December 2024 and of the profit for the financial year then ended; and

• have been properly prepared in accordance with the relevant financial reporting framework and the Applicable Regulations.

The financial statements we have audited comprise:

• the Statement of Financial Position;

• the Statement of Comprehensive Income;

• the Statement of Changes in Net Assets attributable to Holders of Redeemable Participating Shares;

• the Statement of Cash Flows;

• the related notes 1 to 24, including material accounting policy information as set out in note 2; and

• the Schedule of Investments.

The relevant financial reporting framework that has been applied in the preparation of the financial statements is the Irish Collective Asset- Management Vehicles Acts 2015-2020 (“the ICAV Act”) and International Financial Reporting Standards (IFRS) as adopted by the European Union (“the relevant financial reporting framework”).

The applicable regulations that have been applied in their preparation is the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, (as amended) and the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (the “Applicable Regulations”).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (Ireland) (ISAs (Ireland)) and applicable law. Our responsibilities under those standards are described below in the “Auditor's responsibilities for the audit of the financial statements” section of our report.

We are independent of the ICAV in accordance with the ethical requirements that are relevant to our audit of the financial statements in Ireland, including the Ethical Standard issued by the Irish Auditing and Accounting Supervisory Authority (IAASA), as applied to listed entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Summary of our approach

Key audit matters The key audit matters that we identified in the current financial year were:

• Valuation of financial assets at fair value through profit or loss

• Existence of financial assets at fair value through profit or loss

Materiality The materiality that we used in the current year was 1% of Average Net Assets for each Fund.

Scoping We focused our audit scope, and the extent of our testing, based on our assessment of the risks of material misstatement and of the materiality determined.

Significant changes in our There are no significant changes in our approach.

approach

Page 19

/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAVContinued on next page/Valuation of financial assets at fair value through profit or loss

For the financial year ended, the financial assets at fair value through profit or loss represent the most significant balance on the Statement of Financial Position and are a key driver of the total net assets.

• Financial assets at fair value through profit or loss of Chimera S&P UAE UCITS ETF is AED 141,162,125 representing 99% of total net assets of AED 141,399,074.

• Financial assets at fair value through profit or loss of Chimera S&P Pakistan UCITS ETF is PKR 638,270,579 representing 97% of total net assets of PKR 658,728,998.

• Financial assets at fair value through profit or loss of Chimera JP Morgan UAE Bond UCITS ETF is USD 5,038,963 representing 99% of total net assets of USD 5,094,870.

• Financial assets at fair value through profit or loss of Chimera S&P Japan UCITS ETF is JPY 558,730,611 representing 99% of total net assets of JPY 560,071,472.

• Financial assets at fair value through profit or loss of Chimera S&P Germany UCITS ETF is EUR 3,269,095 representing 99% of total net assets of EUR 3,273,531.

The valuation of financial assets at fair value through profit or loss is considered a key audit matter as it represents a significant balance on the Statement of Financial Position. This is also the main driver of the ICAV’s performance and has been identified as the most significant risk of material misstatement.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Our evaluation of the directors’ assessment of the ICAV’s ability to continue to adopt the going concern basis of accounting included:

• As part of our risk assessment procedures, we obtained an understanding of the relevant controls in place regarding going concern.

• Challenged the reasonableness of the key assumptions applied by the directors in their assessment.

• Held discussions with management on the directors’ going concern assessment, the future plans for the ICAV and the feasibility of those plans.

• Reviewed all board meeting minutes during the financial year up to the date of approval of the financial statements, for evidence of any discussions and/or decisions that could impact the ICAV ability to continue as a going concern.

• Reviewed the capital activity and NAV movements, subsequent to the financial year end.

• Assessed the adequacy of the relevant going concern disclosures made in the financial statements

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the ICAV's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Key audit matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current financial year and include the most significant assessed risks of material misstatement (whether or not due to fraud) we identified, including those which had the greatest effect on: the overall audit strategy, the allocation of resources in the audit; and directing the efforts of the engagement team.

These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

Key audit matterdescription

Page 20

/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAVContinued on next page/How the scope of ouraudit responded to thekey audit matter

There is a risk that investments traded on an exchange or a secondary market may not be valued correctly in accordance with IFRS 13.

Refer to note 2(b) and 3 in the financial statements.

We have performed the following procedures to address the key audit matter:

• We obtained BNY Mellon Fund Services (Ireland)’s SOC 1 Report in order to gain an understanding and evaluate the design, implementation and operating effectiveness of key controls over the valuation process for financial assets at fair value through profit or loss; and

• We independently valued equities by using independent market feeds. We compared the prices published by independent pricing sources to the investment portfolio.

Existence of financial assets at fair value through profit or loss

How the scope of our We have performed the following procedures to address the key audit matter: audit responded to the

key audit matter • We obtained the BNY Mellon Fund Services (Ireland)’s SOC 1 Report in order to gain an understanding and evaluate the design, implementation and operating effectiveness of key controls over the reconciliation process for financial assets at fair value through profit or loss; and

• We obtained independent confirmations from the depositary at the financial year end and agreed the amounts held to the investment portfolio.

Key audit matterdescription

For the financial year ended, the financial assets at fair value through profit or loss represent the most significant balance on the Statement of Financial Position and are a key driver of the total net assets.

• Financial assets at fair value through profit or loss of Chimera S&P UAE UCITS ETF is AED 141,162,125 representing 99% of total net assets of AED 141,399,074.

• Financial assets at fair value through profit or loss of Chimera S&P Pakistan UCITS ETF is PKR 638,270,579 representing 97% of total net assets of PKR 658,728,998.

• Financial assets at fair value through profit or loss of Chimera JP Morgan UAE Bond UCITS ETF is USD 5,038,963 representing 99% of total net assets of USD 5,094,870.

• Financial assets at fair value through profit or loss of Chimera S&P Japan UCITS ETF is JPY 558,730,611 representing 99% of total net assets of JPY 560,071,472.

• Financial assets at fair value through profit or loss of Chimera S&P Germany UCITS ETF is EUR 3,269,095 representing 99% of total net assets of EUR 3,273,531.

The existence of financial assets at fair value through profit or loss is considered a key audit matter as it represents a significant balance on the Statement of Financial Position. This is also the main driver of the ICAV’s performance and therefore the existence of the investments is a key audit matter.

The existence and recognition of the ICAV’s investments is crucial to ensuring the financial statements are free from material misstatement. There is a risk that the investments may not exist at financial year end.

Refer to note 2(b) and 3 in the financial statements.

Page 21

/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAVContinued on next page/

Our audit procedures relating to these matters were designed in the context of our audit of the financial statements as a whole, and not to express an opinion on individual accounts or disclosures. Our opinion on the financial statements is not modified with respect to any of the risks described above, and we do not express an opinion on these individual matters.

Our application of materiality

We define materiality as the magnitude of misstatement in the financial statements that makes it probable that the economic decisions of a reasonably knowledgeable person would be changed or influenced. We use materiality both in planning the scope of our audit work and in evaluating the results of our work.

Based on our professional judgement, we determined materiality for the financial statements as a whole as follows:

Materiality AED 1,287,85 (2022: AED 1,701,893) for Chimera S&P UAE UCITS ETF

PKR 4,556,045 (2023: 3,148,167) for Chimera S&P Pakistan UCITS ETFUSD 57,954 for Chimera JP Morgan UAE Bond UCITS ETFJPY 6,796,145 for Chimera S&P Japan UCITS ETFEUR 32,318 for Chimera S&P Germany UCITS ETFBasis fordeterminingmateriality1% of Average Net Assets.Rationale for thebenchmark applied

We have considered the Average Net Assets to be the critical component for determining

materiality because the main objective of the ICAV is to provide investors with a total return and this would be the most important measure for the users of the financial statements.

We set performance materiality at a level lower than materiality to reduce the probability that, in aggregate, uncorrected and undetected misstatements exceed the materiality for the financial statements as a whole. Performance materiality was set at 50% of materiality for the 2024 audit (2023: 50%). In determining performance materiality, we considered the following factors:

o Our understanding of the ICAV;

o The quality of the ICAV’s internal control environment and whether we are able to rely on controls;

o The nature and extent of misstatements identified in previous audits; and

o Expectations in relation to misstatements in the current period.

We agreed with the Board of Directors that we would report to them all audit differences in excess of 5% of materiality, as well as differences below that threshold that, in our view, warranted reporting on qualitative grounds.

We also report to the Board of Directors on disclosure matters that we identified when assessing the overall presentation of the financial statements.

An overview of the scope of our audit

Our audit is a risk-based approach taking into account the structure of the ICAV, types of investments, the involvement of the third party service providers, the accounting processes and controls in place and the industry in which the ICAV operates. The ICAV is incorporated as an Irish collective asset management vehicle with variable capital and authorised by the Central Bank of Ireland (the “CBI”) as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the Applicable Regulations. We have conducted our audit based on the books and records maintained by the administrator BNY Mellon Fund Services (Ireland) at One Dockland Central, Guild Street, IFSC, Dublin 1, Ireland.

Page 22

/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAVContinued on next page/Other information

The other information comprises the information included in the Annual Report and Audited Financial Statements, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the Annual Report and Audited Financial Statements.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view and otherwise comply with the ICAV Act, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the ICAV’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the ICAV or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (Ireland) will always detect a material misstatement when it exists.

Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on IAASA’s website at: https://iaasa.ie/publications/description-of-the-auditors-responsibilities-for-the-audit-of-the-financial-statements. This description forms part of our auditor’s report.

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Identifying and assessing potential risks related to irregularities

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we considered the following:

• the nature of the industry and sector, control environment and business performance;

• results of our enquiries of management and the Board of Directors about their own identification and assessment of the risks of irregularities;

Page 23

/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAVContinued on next page/

• any matters we identified having obtained and reviewed the ICAV's documentation of their policies and procedures relating to: o identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance;

o detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud;

o the internal controls established to mitigate risks of fraud or non-compliance with laws and regulations; and

• the matters discussed among the audit engagement team regarding how and where fraud might occur in the financial statements and any potential indicators of fraud.

As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following areas:

• Risk of fraud in revenue recognition relating to the unrealised movement in fair value of financial assets at fair value through profit or loss.

In common with all audits under ISAs (Ireland), we are also required to perform specific procedures to respond to the risk of management override.

We also obtained an understanding of the legal and regulatory framework that the ICAV operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the ICAV Act and the Applicable Regulations.

In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the ICAV’s ability to operate or to avoid a material penalty. These included matters regulated by the Central Bank of Ireland.

Audit response to risks identified

As a result of performing the above, we did not identify any key audit matters related to the potential risk of fraud or non-compliance with laws and regulations.

In addition to the above, our procedures to respond to risks identified included the following:

• reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;

• enquiring of management and the Board of Directors concerning actual and potential litigation and claims;

• performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;

• reading minutes of meetings of those charged with governance;

• in addressing the risk of fraud in revenue recognition, following completion of the procedures to address the key audit matter that financial assets at fair value through profit or loss may not be valued correctly, we recalculated the unrealised fair value movement on financial assets at fair value through profit or loss by performing a reconciliation and assessing the movement of the fair value of the financial assets at the Statement of Financial Position date from the previous financial year to the current financial year in order to determine the accuracy of the value recognised in the Statement of Comprehensive Income; and

• in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Page 24

/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAVReport on other legal and regulatory requirements Opinionon other matters prescribed by the ICAV Act

Based solely on the work undertaken in the course of the audit, we report that:

• We have obtained all the information and explanations which we consider necessary for the purposes of our audit.

• In our opinion the accounting records of the ICAV were sufficient to permit the financial statements to be readily and properly audited.

• The financial statements are in agreement with the accounting records.

• In our opinion the information given in the directors' report is consistent with the financial statements and the directors’ report has been prepared in accordance with the ICAV Act.

Matters on which we are required to report by exception

Based on the knowledge and understanding of the ICAV and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report.

We have nothing to report in respect of the provisions in the ICAV Act which require us to report to you if, in our opinion, the disclosures of directors’ remuneration and transactions specified by law are not made.

Use of our report

This report is made solely to the ICAV’s members, as a body, in accordance with Section 120(1) (b) of the ICAV Act. Our audit work has been undertaken so that we might state to the ICAV’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the ICAV and the ICAV’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Deborah HunterFor and on behalf of Deloitte Ireland LLP CharteredAccountants and Statutory Audit FirmDeloitte & Touche House, 29 Earlsfort Terrace, Dublin 2Date: 29 April 2025

Page 25

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 22

Statement of Financial PositionChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFAs at31 December2024As at31 December2023As at31 December2024As at31 December2023Notes AED AED PKR PKRAssets

Cash and cash equivalents62,883,6702,520,77921,901,4442,747,144

Financial assets at fair value through profit or loss:

Transferable securities3141,162,125125,540,893638,270,579364,655,675

Total assets144,045,795128,061,672660,172,023367,402,819

Liabilities

Accrued Management fees10(353,521)(315,820)(1,443,025)(840,785)

Distributions Payable(2,293,200)(1,996,400)––

Total liabilities(2,646,721)(2,312,220)(1,443,025)(840,785)

Net assets attributable to holders of

redeemable participating shares14141,399,074125,749,452658,728,998366,562,034

Number of redeemable participating shares

Class A Accumulating Shares4500,000500,000––

Class D Distributing Shares428,000,00028,000,0001,000,0001,000,000

Net asset value per share attributable to holders of redeemable participating shares

Class A Accumulating Shares145.6324.813––

Class D Distributing Shares144.9494.405658.729366.562

The accompanying notes form an integral part of these financial statements.

Page 26

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 23

Statement of Financial Position (continued) Chimera JP

Morgan UAE BondUCITS ETF*Chimera S&PJapanUCITS ETF**Chimera S&PGermanyUCITS ETF***As at31 December2024As at31 December2024As at31 December2024Notes USD JPY EURAssets

Cash and cash equivalents66,9022,789,39012,922

Financial assets at fair value through profit or loss:

Transferable securities35,038,963558,730,6113,269,095

Dividends receivable14292,619–

Interest income receivable55,879––

Total assets5,101,886561,612,6203,282,017

Liabilities

Accrued Management fees10(7,016)(1,541,148)(8,486)

Total liabilities(7,016)(1,541,148)(8,486)

Net assets attributable to holders of redeemable

participating shares145,094,870560,071,4723,273,531

Number of redeemable participating shares

Class D Distributing Shares45,000,0003,500,0003,500,000

Net asset value per share attributable to holdersof redeemable participating shares

Class D Distributing Shares141.019160.0200.935

* Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at 31

December 2023.

** Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at 31 December 2023.

*** Chimera S&P Germany UCITS ETF was launched on 25 September 2024. Therefore, there are no comparatives as at 31

December 2023.On behalf of the Board of Directors:Director:______________________ Director:______________________Feargal Dempsey Syl O'ByrneDate: 23 April 2025

The accompanying notes form an integral part of these financial statements.

Page 27

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 24

Statement of Comprehensive IncomeChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFFinancial Year1 January 2024to 31 December2024Financial Year1 January 2023to 31 December2023Financial Year1 January 2024to 31 December2024Financial Period17 August 2023to 31 December2023

AED AEDPKRPKR

Income

Dividend income6,396,5834,923,28637,431,33613,552,989

Net gains/(losses) on financial assets at fair

value through profit or loss515,553,206(1,042,618)290,114,84158,176,916

Total investment income21,949,7893,880,668327,546,17771,729,905

Operating expenses

Management fees8,10(1,274,167)(1,283,838)(4,564,927)(1,167,871)

Capital gains taxes7––(1,849,986)–

Total operating expenses(1,274,167)(1,283,838)(6,414,913)(1,167,871)

Net income20,675,6222,596,830321,131,26470,562,034

Finance costsDistributions to holders of redeemable

participating shares16(5,026,000)(3,710,300)(28,964,300)–

Total finance costs(5,026,000)(3,710,300)(28,964,300)–

Profit/(loss) for the financial year/period

before tax15,649,622(1,113,470)292,166,96470,562,034

Increase/(decrease) in net assets resultingfrom operations attributable to holders of

redeemable participating shares15,649,622(1,113,470)292,166,96470,562,034

Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.

The accompanying notes form an integral part of these financial statements.

Page 28

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 25

Statement of Comprehensive Income (continued) Chimera JP

Morgan UAE BondUCITS ETF*Chimera S&PJapanUCITS ETF**Chimera S&PGermanyUCITS ETF***Financial Period25 March 2024to 31 December2024Financial Period28 May 2024to 31 December2024Financial Period25 September 2024to 31 December2024USD JPY EURIncome

Interest income218,586––

Dividend income1425,866,7185

Net (losses)/gains on financial assets at fair

value through profit or loss5(80,106)11,044,582135,500

Total investment income138,62216,911,300135,505

Operating expenses

Management fees8,10(22,306)(3,986,392)(8,486)

Other operating expenses162–12

Total operating expenses(22,144)(3,986,392)(8,474)

Net income116,47812,924,908127,031

Finance costs

Interest expense(107)(436)–

Total Finance costs(107)(436)–

Profit for the financial year/period before

tax116,37112,924,472127,031

Increase in net assets resulting fromoperations attributable to holders of

redeemable participating shares116,37112,924,472127,031

* Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives for the financial year ended 31 December 2023.

** Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives for the financial year ended 31 December 2023.

*** Chimera S&P Germany UCITS ETF was launched on 25 September 2024. Therefore, there are no comparatives for the financial year ended 31 December 2023.

Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.

The accompanying notes form an integral part of these financial statements.

Page 29

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 26

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares Chimera S&P

UAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFFinancial Year1 January 2024to 31 December2024Financial Year1 January 2023to 31 December2023Financial Year1 January 2024to 31 December2024Financial Period17 August 2023to 31 December2023

AED AEDPKRPKR

Net assets attributable to holders of redeemable participating shares at

beginning of the financial year/period125,749,452131,433,922366,562,034–

Increase/(decrease) in net assets resulting from operations attributable to holders of

redeemable participating shares15,649,622(1,113,470)292,166,96470,562,034

Issue of redeemable participating shares–––296,000,000

Redemption of redeemable participating

shares–(4,571,000)––

(Decrease)/increase in net assets resulting

from share transactions–(4,571,000)–296,000,000

Net assets attributable to holders of redeemable participating shares at end of

the financial year/period141,399,074125,749,452658,728,998366,562,034

The accompanying notes form an integral part of these financial statements.

Page 30

Chimera UCITS ICAV

Annual Report & Audited Financial Statements For the financial year ended 31 December 2024 27

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares (continued) Chimera JP

Morgan UAE BondUCITS ETF*Chimera S&PJapanUCITS ETF**Chimera S&PGermanyUCITS ETF***Financial Period25 March 2024to 31 December2024Financial Period28 May 2024to 31 December2024Financial Period25 September 2024to 31 December2024USD JPY EUR

Net assets attributable to holders of redeemable participating shares at

beginning of the financial year/period – – – Increase in net assets resulting from operations attributable to holders of

redeemable participating shares116,37112,924,472127,031

Issue of redeemable participating shares6,500,000942,000,0003,146,500

Redemption of redeemable participating

shares(1,521,501)(394,853,000)–

Increase in net assets resulting from share

transactions4,978,499547,147,0003,146,500

Net assets attributable to holders ofredeemable participating shares at end of

the financial year/period5,094,870560,071,4723,273,531

* Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives for the financial year ended 31 December 2023.

** Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives for the financial year ended 31 December 2023.

*** Chimera S&P Germany UCITS ETF was launched on 25 September 2024. Therefore, there are no comparatives for the financial year ended 31 December 2023.

The accompanying notes form an integral part of these financial statements.

Show all 83 pages